Cell-mediated Immune Responses
Antigens Involved in Adaptive Immunity
Tissue Transplantation
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Mar 1, 2026

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors
Published on: December 16, 2022
1Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea; Transplantation Research Center, Samsung Biomedical Research Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Mixed allogeneic chimeras enhance anti-cancer immunity. This study shows that these chimeric environments sustain both primary and memory T-cell responses against tumors, suggesting potential for cancer therapy.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: